ES522459A0 - Un procedimiento para la preparacion de un derivado de ascoclorina. - Google Patents

Un procedimiento para la preparacion de un derivado de ascoclorina.

Info

Publication number
ES522459A0
ES522459A0 ES522459A ES522459A ES522459A0 ES 522459 A0 ES522459 A0 ES 522459A0 ES 522459 A ES522459 A ES 522459A ES 522459 A ES522459 A ES 522459A ES 522459 A0 ES522459 A0 ES 522459A0
Authority
ES
Spain
Prior art keywords
ascochlorine
derivative
procedure
preparation
ascochlorine derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES522459A
Other languages
English (en)
Other versions
ES8406995A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP14166081A external-priority patent/JPS5843938A/ja
Priority claimed from JP16882181A external-priority patent/JPS5869860A/ja
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of ES8406995A1 publication Critical patent/ES8406995A1/es
Publication of ES522459A0 publication Critical patent/ES522459A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/14Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708Ethers
    • C07C69/712Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES522459A 1981-09-10 1983-05-16 Un procedimiento para la preparacion de un derivado de ascoclorina. Granted ES522459A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14166081A JPS5843938A (ja) 1981-09-10 1981-09-10 アスコクロリン誘導体
JP16882181A JPS5869860A (ja) 1981-10-23 1981-10-23 アスコクロリン誘導体

Publications (2)

Publication Number Publication Date
ES8406995A1 ES8406995A1 (es) 1984-08-16
ES522459A0 true ES522459A0 (es) 1984-08-16

Family

ID=26473856

Family Applications (2)

Application Number Title Priority Date Filing Date
ES515648A Expired ES8400382A1 (es) 1981-09-10 1982-09-10 Un derivado de ascoclorina
ES522459A Granted ES522459A0 (es) 1981-09-10 1983-05-16 Un procedimiento para la preparacion de un derivado de ascoclorina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES515648A Expired ES8400382A1 (es) 1981-09-10 1982-09-10 Un derivado de ascoclorina

Country Status (9)

Country Link
US (2) US4500544A (es)
EP (1) EP0074628B1 (es)
KR (1) KR880002433B1 (es)
AR (1) AR242373A1 (es)
CA (1) CA1192557A (es)
CS (1) CS244911B2 (es)
DE (1) DE3271383D1 (es)
ES (2) ES8400382A1 (es)
MX (1) MX157777A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409951A (en) * 1990-06-15 1995-04-25 Novo Nordisk A/S Fungicidally active compounds
US5139481A (en) * 1991-08-07 1992-08-18 The General Hospital Corporation Treatment for type II diabetes
JPH0816057B2 (ja) * 1992-09-10 1996-02-21 田村 學造 グリケイション阻害剤
US5420334A (en) * 1994-04-04 1995-05-30 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CA2183167A1 (en) 1994-12-13 1996-06-20 Peter K. Law Myoblast therapy for mammalian diseases
BR9610207A (pt) * 1995-08-28 1999-02-02 American Home Prod Acidos fenóxi acéticos como inibidores da aldose redutase e agentes anti-hiperglicêmicos
CA2355299A1 (en) 1998-12-14 2000-06-22 Takafumi Uchida Novel ligands of nuclear receptor
MXPA01009127A (es) * 1999-03-11 2003-07-14 Nuclear Receptor Res Ltd Ligandos novedosos de receptores nucleares, receptores activados por proliferacion de peroxisoma.
JPWO2003063849A1 (ja) * 2002-01-31 2005-05-26 アリジェン株式会社 多重危険因子症候群の診断、予防又は治療用医薬組成物
US9662314B2 (en) 2011-10-21 2017-05-30 Tufts Medical Center, Inc. Compounds and methods for the treatment of muscular disease, and related screening methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3546073A (en) * 1968-08-13 1970-12-08 American Cyanamid Co Fusarium fermentation
US3995061A (en) * 1974-04-09 1976-11-30 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition and method of using the same

Also Published As

Publication number Publication date
ES8406995A1 (es) 1984-08-16
EP0074628A3 (en) 1984-01-18
CA1192557A (en) 1985-08-27
MX157777A (es) 1988-12-09
EP0074628A2 (en) 1983-03-23
KR840001543A (ko) 1984-05-07
DE3271383D1 (en) 1986-07-03
ES515648A0 (es) 1983-11-01
ES8400382A1 (es) 1983-11-01
CS244911B2 (en) 1986-08-14
AR242373A1 (es) 1993-03-31
KR880002433B1 (ko) 1988-11-12
US4542143A (en) 1985-09-17
US4500544A (en) 1985-02-19
EP0074628B1 (en) 1986-05-28
CS652682A2 (en) 1985-09-17

Similar Documents

Publication Publication Date Title
ES517542A0 (es) Un procedimiento para la preparacion de derivados de 3-hidroxi-ml-236-b.
ES518225A0 (es) Un procedimiento para la preparacion de nuevos derivados de oxabicicloalcano.
ES517222A0 (es) Un procedimiento para la preparacion de derivados de acilmorrfinano.
ES512880A0 (es) Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina.
ES514264A0 (es) Un procedimiento para la preparacion de derivados de tiazolidi-nilalquilen-piperazinas.
ES509437A0 (es) Un procedimiento para la preparacion de derivados carbapenen-2-tio-sustituidos.
ES516825A0 (es) Un procedimiento para la preparacion de nuevos derivados de 3-amino-pregn-5-eno.
ES513880A0 (es) Un procedimiento para la preparacion de derivados de triazolurea.
ES521471A0 (es) Un procedimiento para la preparacion de un derivado de carbostirilo.
ES510067A0 (es) Un procedimiento para la preparacion de nuevos derivados de benzoilurea.
ES515655A0 (es) Un procedimiento para la preparacion de derivados de benzotiazolina.
ES518975A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-piperazino primidina.
ES510611A0 (es) Un procedimiento para la preparacion de derivados de desoxiuridina.
ES513967A0 (es) Un procedimiento para la preparacion de derivados de etanola-mina.
ES522459A0 (es) Un procedimiento para la preparacion de un derivado de ascoclorina.
ES518295A0 (es) Un procedimiento para la preparacion de un derivado de piridoindol.
ES514263A0 (es) Un procedimiento para la preparacion de derivados de espiroti-azolidinil-piperazina.
ES514213A0 (es) Un procedimiento para la preparacion de nuevos derivados poliprenilicos.
ES508775A0 (es) Un procedimiento para la preparacion de derivados de ciclo- hepteno.
ES517852A0 (es) Un procedimiento para la preparacion de derivados de bencenosulfonamidas.
ES521021A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES512463A0 (es) Un procedimiento para la preparacion de un derivado de beta-lactama.
ES515365A0 (es) Un procedimiento para la preparacion de un derivado de furanocremona.
ES514486A0 (es) Un procedimiento para la preparacion de derivados de aminonaftaceno.
ES521679A0 (es) Un procedimiento para la preparacion de derivados de trifluormetanosulfonanilida.